Clik here to view.
Introducing FDA’s emerging sciences idea portal: Please help us predict the...
By: Donna L. Mendrick, Ph.D. Gazing into the future to predict the next new things in science and technology is not just the work of a science fiction writer. Government and business engage in this...
View ArticleClik here to view.
Third-quarter sales surge more than 50% for Mazor Robotics
Third-quarter sales for Mazor Robotics (NSDQ:MZOR) rose nearly 54% as the robot-assisted surgery company sold more guidance systems than during all of last year. Caesarea, Israel-based Mazor posted...
View ArticleClik here to view.
Japan OKs Medinol stent trial
Medinol said yesterday that Japanese regulators approved a clinical trial of its Elunir drug-eluting stent that it plans to add to an ongoing U.S. trial of the device. The thin-strut,...
View ArticleClik here to view.
Catalent tops Q1 estimates, profits fall 61%
Shares in Catalent (NYSE:CTLT) rose yesterday after the drug-delivery company met expectations on Wall Street with its fiscal 1st-quarter results. The Somerset, N.J.-based company posted profits of...
View ArticleClik here to view.
Haemonetics tops Q2 earnings forecast by 11c
Haemonetics (NYSE:HAE) yesterday posted fiscal 2nd-quarter numbers that topped expectations on Wall Street by more than a dime, despite flat sales growth, as the company executes a reorganization plan....
View ArticleClik here to view.
Stanford uses CRISPR to correct sickle cell, human trials planned
Researchers from the Stanford University School of Medicine have reportedly used CRISPR, a gene-editing tool, to repair the gene that causes sickle cell disease. The team is planning the 1st human...
View ArticleClik here to view.
Senate panel adds to call for hearings over Mylan’s EpiPen pricing
The U.S. Senate Judiciary Committee yesterday called on the Federal Trade Commission to investigate whether Mylan (NSDQ:MYL) broke the law after reports claimed the EpiPen maker prevented schools from...
View ArticleClik here to view.
Positive 1-month safety results for Medtronic’s Navigate bronchoscopy trial
Medtronic (NYSE:MDT) today released 1-month data from the Navigate trial of its superDimension LungGPS system, touting the device as safe and effective based on the preliminary results. A total of...
View ArticleClik here to view.
Inspire Medical Systems raises $13m for sleep apnea device
Inspire Medical Systems has raised $12.5 million in a new round of equity financing, according to an SEC filing posted today. Inspire Medical developed and produces a sleep apnea implant, a...
View ArticleClik here to view.
Ex-Hologic sales rep files age discrimination lawsuit
A former Hologic (NSDQ:HOLX) employee is suing the company claiming he was let go because of his age, according to court documents filed last month. The complainant, Eric Babcock, filed the suit with...
View ArticleClik here to view.
Hologic inks collab deal with Seegene
Seegene (KSDQ:096530) said today that it inked a collaboration deal with Hologic (NSDQ:HOLX) to develop high-multiplex, real-time PCR reagents for the developing Hologic Panther Fusion system....
View ArticleClik here to view.
UPDATE: BTG’s U.S. Biocompatibles business to pay $36m settlement, plead...
Updated to include BTG’s guilty plea entered Nov 7. BTG (LON:BTG) said last month that it agreed to pay the U.S. Justice Dept. $36 million (£28.4 million) to settle a probe into the marketing of the...
View ArticleClik here to view.
Clearside Biomedical names VP business development | Personnel Moves, Nov. 8,...
Clearside Biomedical (NSDQ:CLSD) today named Rick McElheny as its VP of business development. The Alpharetta, Ga.-based company is developing a microinjector loaded with CLS-TA (triamcinolone...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for November 8, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
pSivida misses Q3 estimates, profits slide 47%
Shares in pSivida (NSDQ:PSDV) fell 6% today after the company missed expectations on Wall Street with its fiscal 1st-quarter results. The Watertown, Mass.-based company posted losses of -$7.2 million,...
View ArticleClik here to view.
Boston Scientific launches Dakota nitinol kidney stone retrieval device
Boston Scientific (NYSE:BSX) said today it launched its Dakota nitinol retrieval device designed for kidney stone retrieval in the U.S. and Europe. The Dakota stone retrieval device is designed to work...
View ArticleClik here to view.
ECRI lists the top 10 medical device hazards
The ECRI Institute this month released its top 10 health technology hazards for the next year, with Infusion errors and inadequate cleaning of reusable instruments topping the list. The ECRI institute...
View ArticleClik here to view.
Baxter adds $1.5B to share buyback plan
Baxter (NYSE:BAX) said today its board of directors approved a $1.5 billion increase in its share repurchase plan as it announced its quarterly cash dividend of 13¢. The share repurchase plan, which...
View ArticleClik here to view.
DJO Global pares losses down over 80% in Q3 earnings
DJO Global today released its 3rd quarter earnings, seeing losses pared down 87% while sales grew just over 3%. The San Diego, Calif.-based company posted losses of $22.5 million on sales of $287...
View ArticleClik here to view.
Appeals court reverses AngioScore win over TriReme
The U.S. Court of Appeals for the Federal Circuit overturned a ruling in favor of AngioScore in a patent infringement case between it and TriReme Medical and a pair of related companies. The court...
View Article